Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
The Oncologist|March 30, 2026
Degrees of H2AX phosphorylation correlate with unique features of the intratumoral immune microenvironment in colorectal carcinomasEnrico Berrino, Sara Erika Bellomo, Maria Costanza Aquilano, et al.
Nature Communications|May 1, 2015
The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsEnzo Medico, Mariangela Russo, Gabriele Picco, et al.
Cancer Immunology Research|February 27, 2019
Combined Low Densities of FoxP3+ and CD3+ Tumor-Infiltrating Lymphocytes Identify Stage II Colorectal Cancer at High Risk of ProgressionTommaso Cavalleri, Paolo Bianchi, Gianluca Basso, et al.
British Journal of Cancer|December 4, 2015
Novel CAD-ALK gene rearrangement is drugable by entrectinib in colorectal cancerAlessio Amatu, Alessio Somaschini, Giulio Cerea, et al.
The Oncologist|April 7, 2019
HER2 Positivity Predicts Unresponsiveness to EGFR-Targeted Treatment in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Alessio Amatu, Luca Porcu, et al.
International Journal of Cancer|February 14, 2013
KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapyEmanuele Valtorta, Sandra Misale, Andrea Sartore-Bianchi, et al.
Nature Communications|December 9, 2016
Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancerBeth O Van Emburgh, Sabrina Arena, Giulia Siravegna, et al.
Journal of Clinical Pathology|May 27, 2018
TRKA expression and NTRK1 gene copy number across solid tumoursGianluca Mauri, Emanuele Valtorta, Giulio Cerea, et al.
Journal of the National Cancer Institute|November 14, 2015
Sensitivity to Entrectinib Associated With a Novel LMNA-NTRK1 Gene Fusion in Metastatic Colorectal CancerAndrea Sartore-Bianchi, Elena Ardini, Roberta Bosotti, et al.
Pageof 5